The Centres of Excellence in Neurodegenerative Disease (CoEN) initiative has awarded £3.6 million to 11 international “Pathfinder” innovation projects. These projects aim to identify and validate new potential drugs and develop innovative therapeutic approaches for the dementia, and other conditions such as Parkinson’s Disease and Motor Neuron Disease.
“CoEN is an international initiative involving research funders in Belgium (Vlaams Instituut voor Biotechnologie, Flanders), Canada (Canadian Institutes of Health Research (CHIR)), France (Agence Nationale de la Recherche (ANR)), Germany (Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)), Ireland (Science Foundation Ireland (SFI)), Italy (Ministry of Health), Slovakia (Slovak Ministry of Education, Science, Research and Sport), Spain (Instituto de Salud Carlos III (ISCIII) and the UK (Medical Research Council (MRC)). The aim of the initiative is to encourage collaborative research between recognised national centres of excellence in neurodegeneration research”.
New Pathfinder award funding for international collaborations between Centres of Excellence in neurodegenerative disease research. London: Medical Research Council (MRC), December 21st 2015.